ATR inhibition enables complete tumour regression in ALK-driven NB mouse models

High-risk neuroblastoma (NB) often involves MYCN amplification as well as mutations in ALK. Currently, high-risk NB presents significant clinical challenges, and additional therapeutic options are needed. Oncogenes like MYCN and ALK result in increased replication stress in cancer cells, offering th...

Popoln opis

Bibliografske podrobnosti
Autores principales: Szydzik, Joanna, Lind, Dan E., Arefin, Badrul, Kurhe, Yeshwant, Umapathy, Ganesh, Siaw, Joachim Tetteh, Claeys, Arne, Gabre, Jonatan L., Van den Eynden, Jimmy, Hallberg, Bengt, Palmer, Ruth H.
Format: Online Artículo Texto
Jezik:English
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online dostop:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613282/
https://www.ncbi.nlm.nih.gov/pubmed/34819497
http://dx.doi.org/10.1038/s41467-021-27057-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613282/
https://www.ncbi.nlm.nih.gov/pubmed/34819497
http://dx.doi.org/10.1038/s41467-021-27057-2

Podobne knjige/članki